Published: Mar 25, 2026
Written by Klarity Editorial Team
Published: Mar 25, 2026

If you’re managing bipolar disorder, you’ve likely wondered: Can I get my mood stabilizers through a telehealth appointment? The short answer is yes—and it’s easier than you might think. Unlike controlled substances such as ADHD stimulants or benzodiazepines, the most common bipolar medications (Lithium, Lamictal, and Seroquel) aren’t subject to the same federal restrictions, making telehealth a safe, legal, and convenient option for many patients.
But the longer answer depends on where you live, who’s prescribing, and how telehealth laws have evolved since the COVID-19 pandemic. This guide breaks down everything you need to know about getting bipolar treatment online in 2025-2026, including federal rules, state-by-state differences, and what to expect from your virtual psychiatry visit.
Bipolar disorder affects approximately 2.8% of U.S. adults, yet access to psychiatric care remains limited in many areas. Long wait times, provider shortages, and geographic barriers keep countless people from getting timely treatment. Telehealth bridges that gap—offering psychiatric evaluations, medication management, and follow-up care from the comfort of home.
For many patients, virtual care means:
Platforms like Klarity Health specialize in connecting patients with licensed providers who can diagnose and treat bipolar disorder via secure video visits—often with same-week availability and upfront pricing (typically accepting both insurance and self-pay options).
Here’s what matters most: Common bipolar medications are not controlled substances under federal law, so there’s no DEA-mandated in-person visit requirement before you can receive a prescription via telehealth.
✅ Lithium (Lithium carbonate) – Unscheduled; fully prescribable via telehealth
✅ Lamictal (Lamotrigine) – Unscheduled; fully prescribable via telehealth
✅ Seroquel (Quetiapine) – Unscheduled; fully prescribable via telehealth
These medications are governed by the same telemedicine rules as antidepressants or blood pressure drugs—not the stricter regulations that apply to opioids, stimulants, or benzodiazepines. That means a licensed psychiatrist or psychiatric nurse practitioner can evaluate you over a video call, confirm a bipolar diagnosis, and electronically send a prescription to your pharmacy.
You may have heard about the Ryan Haight Online Pharmacy Consumer Protection Act—a 2008 federal law designed to prevent online prescription drug abuse. This law requires an in-person medical exam before prescribing controlled substances (Schedule II-V drugs) via the internet.
Here’s the key: Lithium, Lamictal, and Seroquel are not controlled substances. The Ryan Haight Act simply doesn’t apply to them. Federal law has always allowed telemedicine prescribing of non-controlled medications, provided the doctor-patient relationship and standard of care are met.
During the pandemic, the DEA temporarily waived the in-person requirement for controlled substances—allowing providers to prescribe ADHD stimulants, certain anxiety medications, and other regulated drugs via telehealth. As of January 2, 2026, this flexibility has been extended through December 31, 2026, giving Congress more time to finalize permanent telehealth rules.
While this extension primarily affects controlled medications, it underscores the federal government’s commitment to expanding telehealth access. For bipolar patients, it means the regulatory environment continues to support virtual psychiatric care.
While federal law permits telehealth prescribing of bipolar medications nationwide, state laws add an extra layer of regulation. Some states have specific requirements about how telehealth visits must be conducted, who can prescribe, and whether periodic in-person check-ins are needed.
The vast majority of states allow bipolar medications to be prescribed via telehealth with no mandatory in-person visit—as long as the virtual exam meets the standard of care. This includes:
New Hampshire stands out with a unique rule: if you’re receiving ongoing treatment via telemedicine, the law requires at least one telehealth evaluation per year to ensure continuity of care. This can still be done virtually—it just means your provider will schedule an annual comprehensive check-in.
Several states made telehealth changes in 2025:
Bottom line: No state we reviewed prohibits telehealth prescribing of Lithium, Lamictal, or Seroquel. The differences are in how telehealth must be conducted, not whether it’s allowed.
Medical doctors (MDs and DOs) with psychiatric training can prescribe all bipolar medications via telehealth in every state, as long as they’re licensed where you live. Platforms like Klarity Health ensure your provider is properly credentialed in your state.
In many states, psychiatric nurse practitioners can independently diagnose and treat bipolar disorder—including prescribing mood stabilizers. As of 2025, over 30 states grant NPs full practice authority, meaning they don’t need a physician’s supervision.
States where NPs have independent practice (for non-controlled meds like bipolar treatment):
States requiring NP-physician collaboration:
Even in ‘collaborative’ states, NPs can still prescribe Lithium, Lamictal, and Seroquel via telehealth—they just work under a formal agreement with a supervising physician. The collaboration doesn’t limit access; it’s simply a regulatory structure.
Physician Assistants (PAs) also prescribe these medications in most states, typically under some level of physician oversight (PA independent practice is rare nationwide).
Klarity Health employs both psychiatrists and psychiatric nurse practitioners, ensuring you’re matched with a qualified provider no matter your state’s regulations.
Your first appointment will be a comprehensive video assessment—typically 30-60 minutes. The provider will:
This is just as thorough as an in-person visit. Reputable providers like those at Klarity Health won’t rush the evaluation—they need detailed information to prescribe safely.
If medication is appropriate, your provider will:
For Lithium, expect an order for baseline lab tests (kidney and thyroid function, electrolytes). You’ll visit a local lab for blood work, and the provider reviews results before finalizing your prescription.
For Lamictal, the provider will start you on a low dose and gradually increase it (to minimize rash risk). You may receive a ‘starter pack’ prescription with built-in titration.
For Seroquel, the provider may discuss off-label use (it’s FDA-approved for bipolar mania and as an add-on for depression) and monitoring for metabolic side effects.
Telehealth providers typically require regular check-ins—often every 1-3 months initially, then quarterly once you’re stable. These follow-ups can usually be done via video or phone.
Your provider will:
Because these medications aren’t controlled substances, refills are straightforward. Many providers will prescribe a 30-90 day supply with refills, depending on your stability and state regulations.
Reality: Licensed telehealth psychiatrists and NPs have the same prescribing authority as in-person providers. They can prescribe Lithium, Lamictal, Seroquel, and most other psychiatric medications (with temporary federal allowances even covering controlled substances through 2026).
Reality: Legitimate platforms require comprehensive evaluations. Klarity Health and similar services involve detailed intake questionnaires, 30+ minute video assessments, and careful diagnostic review. Any service promising instant prescriptions without proper evaluation is a red flag.
Reality: Lithium, Lamictal, and Seroquel are not controlled substances. They’re in the same legal category as antidepressants or blood pressure medications—no special DEA restrictions apply.
Reality: Studies show telehealth psychiatric care is just as effective as in-person treatment for many conditions, including bipolar disorder. Providers must meet the same standards of care, documentation requirements, and clinical guidelines whether the visit is virtual or face-to-face.
Reality: While telehealth can handle most routine bipolar management, you may need in-person care for certain situations—like severe mania requiring hospitalization, complex medication adjustments with physical symptoms, or neurological side effects. Good telehealth providers know when to refer you for higher-level care.
You might wonder: Will my telehealth doctor check my prescription history?
Prescription Drug Monitoring Programs (PDMPs) are state databases that track controlled substance prescriptions. Most states require PDMP checks before prescribing opioids, stimulants, or benzodiazepines.
Since Lithium, Lamictal, and Seroquel aren’t controlled, PDMP checks are typically not legally required. However, many responsible telehealth providers still review your PDMP profile as a precaution—especially to:
Seroquel note: While not controlled, Quetiapine is sometimes tracked in state PDMPs as a ‘drug of concern’ due to occasional misuse. Your provider may check for repeated early refills or overlapping prescribers.
Your privacy is protected under HIPAA and state telehealth confidentiality laws. Providers access PDMP data only for legitimate treatment purposes.
Telehealth works well for:
Telehealth may not be appropriate if you have:
Reputable providers will triage your case and recommend in-person evaluation if needed.
🚩 Promises of guaranteed prescriptions before evaluation
🚩 No video requirement (audio-only or text-based ‘prescribing’)
🚩 Extremely short consultations (under 15 minutes for an initial bipolar evaluation)
🚩 No discussion of monitoring or follow-up (especially concerning for Lithium)
🚩 Sending medications directly (bypassing licensed pharmacies)
🚩 Unlicensed or out-of-state providers (your doctor must be licensed in your state)
Choose platforms that use board-certified or board-eligible psychiatrists and psychiatric NPs, require live video visits, and maintain transparent pricing and licensing information. Klarity Health, for example, prominently displays provider credentials and ensures all clinicians are licensed in the states where they practice.
If you’re considering telehealth for bipolar disorder, Klarity Health offers:
Klarity Health’s platform is designed to make quality mental health care accessible and affordable—whether you’re newly diagnosed with bipolar disorder or looking for better medication management than you’ve received elsewhere.
Most health insurance plans cover telehealth psychiatric visits at the same rate as in-person care. Under pandemic-era policies (many now permanent), insurers cannot discriminate against telehealth modality. Check your plan’s mental health benefits—many cover:
Klarity Health accepts many major insurance plans and can verify your coverage before your first visit.
If you’re uninsured or prefer not to use insurance, telehealth platforms often offer transparent cash-pay pricing. Typical costs:
Self-pay can be advantageous for those who want to keep mental health treatment off their insurance record or who have high-deductible plans.
Yes. Lithium is not a controlled substance and can be prescribed via telehealth in all 50 states. However, because Lithium requires regular blood level monitoring (to prevent toxicity), your provider will order lab tests before starting treatment and periodically afterward. You’ll visit a local lab for blood draws, and results are reviewed remotely.
No. For non-controlled bipolar medications, no state requires an initial in-person visit. A thorough telehealth video evaluation satisfies legal and medical standards in all states (New Hampshire requires annual telehealth check-ins for ongoing treatment, but these can still be virtual).
Yes. Psychiatric nurse practitioners can prescribe Lithium, Lamictal, and Seroquel in all states—either independently (in 30+ states) or under physician collaboration (in others). Klarity Health employs both psychiatrists and NPs to ensure coverage nationwide.
Yes. Your provider will send an electronic prescription to the pharmacy of your choice. You pick up your medication just like any other prescription. Telehealth platforms do not ship medications directly—they work through licensed pharmacies for safety and legality.
Typically every 1-3 months initially, then quarterly once stable. Lithium users may need more frequent lab monitoring (every 3-6 months). Follow-ups can usually be done via telehealth, though some providers may request an occasional in-person visit if clinical concerns arise.
Research indicates comparable outcomes for telehealth and in-person psychiatric care, especially for medication management and monitoring. The key is choosing a reputable provider who conducts thorough evaluations and maintains regular contact.
The temporary DEA flexibilities for controlled substances are set to expire December 31, 2026 unless extended or replaced with permanent regulations. Congress is considering several bills (including the Telehealth Modernization Act) to establish long-term telehealth frameworks.
For bipolar medications (non-controlled), these pending changes won’t directly impact you—federal law already permits telehealth prescribing. However, broader telehealth reform could:
Stay informed, but rest assured: telehealth access to bipolar treatment is here to stay.
If you’re ready to explore telehealth for bipolar disorder:
Telehealth makes quality psychiatric care more accessible than ever. With transparent pricing, fast appointment availability, and licensed providers who understand bipolar disorder, platforms like Klarity Health are helping thousands of patients take control of their mental health—from the comfort and privacy of home.
Ready to get started? Visit Klarity Health to schedule your initial psychiatric evaluation and explore your medication options today.
The following sources provided the regulatory and clinical foundation for this article:
HHS.gov Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities Through 2026’ (January 2, 2026). Available at: https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
DEA.gov Announcement – ‘DEA and HHS Extend Telemedicine Flexibilities through 2025’ (November 15, 2024). Available at: https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall
DEA.gov Press Release – ‘DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care’ (December 31, 2025). Available at: https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care
Ryan Haight Act Analysis via Sheppard Mullin Health Law Blog (2017). Available at: https://www.sheppardhealthlaw.com/2017/07/articles/health-information-technology/online-pharmacies/
Sheppard Mullin Law Blog – ‘Telehealth and In-Person Visits: Federal and State Updates’ (August 15, 2025). Available at: https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/
Disclaimer: This article is for informational purposes only and does not constitute medical or legal advice. Telehealth regulations vary by state and are subject to change. Always consult with a licensed healthcare provider for personalized medical guidance.
Find the right provider for your needs — select your state to find expert care near you.